Jump to content
Crime Forum
FORUMS BLOG/NEWS USER BLOGS USER MEDIA ADVERTS   ADD  MANAGE CHAT CLUBS & USER'S PERSONAL FORUMS LINK EXCHANGE

More than 100 industry players and over 60 non-industry players currently claim to manufacture\RootsAnalysis


Owing to various reasons, the demand for cell therapies is anticipated to increase over the coming years. Therefore, both therapy developers and contract service providers may need to strengthen their capabilities and expand available capacity. In this context, automation is expected to be a key enabler within the cell therapy manufacturing and contract services industry

 

To order this 550+ page report, which features 160+ figures and 250+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

 

The USD 11 billion (by 2030) financial opportunity within the cell therapy manufacturing market has been analyzed across the following segments:

§  Type of therapy

§  T-cell therapies (CAR-T therapies, TCR therapies, TIL therapies)

§  Dendritic cell therapies

§  Tumor cell therapies

§  NK cell therapies

§  Stem cell therapies

 

§  Source of cells

§  Autologous

§  Allogeneic

 

§  Scale of operation

§  Clinical

§  Commercial

 

§  Purpose of manufacturing

§  Contract manufacturing

§  In-house manufacturing

 

§  Key geographical regions

§   North America

§   Europe

§   Asia Pacific

§   Rest of the world

 

The Cell Therapy Manufacturing Market (3rd Edition), 2019 - 2030 report features the following companies, which we identified to be key players in this domain:

§  BioNTech Innovative Manufacturing Services

§  Cell Therapies

§  Cell and Gene Therapy Catapult

§  Center for Cell and Gene Therapy, Baylor College of Medicine

§  Centre for Cell Manufacturing Ireland, National University of Ireland

§  Clinical Cell and Vaccine Production Facility, University of Pennsylvania

§  Cognate BioServices

§  FUJIFILM

§  Guy’s and St. Thomas’ GMP Facility, Guy’s Hospital

§  Hitachi Chemical

§  KBI Biopharma

§  Laboratory for Cell and Gene Medicine, Stanford University

§  Lonza

§  MaSTherCell

§  MEDINET

§  Molecular and Cellular Therapeutics, University of Minnesota

§  Newcastle Cellular Therapies Facility, Newcastle University

§  Nikon CeLL innovation

§  Rayne Cell Therapy Suite, King’s College London

§  Roslin Cell Therapies

§  Scottish National Blood Transfusion Services Cellular Therapy Facility, Scottish Centre for Regenerative Medicine

§  Sydney Cell and Gene Therapy

§  WuXi Advanced Therapies

 

Table of Contents

 

1. Preface

2. Executive Summary


3. Introduction
 

4. Market Overview

 

5. Regulatory Landscape
 

6. Roadmaps for Overcoming Existing Challenges

 

7. Automation Technologies for Cell Therapy Manufacturing
 

8. Profiles: Industry Players
 

9. Profiles: Non-Industry Players
 

10. Role of Non-Profit Organizations
 

11. Partnerships
 

12. Facility Expansions
 

13. Capacity Analysis

 

14. Demand Analysis

 

15. Cost Price Analysis

 

16. Make Versus Buy Decision Making Framework

 

17. Market Sizing and Opportunity Analysis

 

18. Key Insights

 

19. SWOT Analysis

 

20. Conclusion

 

21. Survey Analysis

 

22. Interview Transcripts

 

23. Appendix 1: Tabulated Data

 

24. Appendix 2: List of Companies and Organizations

 

To purchase a copy, please visit-  https://www.rootsanalysis.com/reports/view_document/cell-therapy-manufacturing/285.html

 

Contact Details

Gaurav Chaudhary

+1 (415) 800 3415

gaurav.chaudhary@rootsanalysis.com  

 

0 Comments


Recommended Comments

There are no comments to display.

Guest
Add a comment...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
  • Create New...